Predictive Oncology Inc (NASDAQ: POAI) kicked off on Monday, down -9.35% from the previous trading day, before settling in for the closing price of $1.39. Over the past 52 weeks, POAI has traded in a range of $0.55-$3.17.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 6.59% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 40.23%. With a float of $7.09 million, this company’s outstanding shares have now reached $7.21 million.
In an organization with 34 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 7.89%, operating margin of -958.27%, and the pretax margin is -954.17%.
Predictive Oncology Inc (POAI) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Predictive Oncology Inc is 1.59%, while institutional ownership is 3.34%.
Predictive Oncology Inc (POAI) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.23% per share during the next fiscal year.
Predictive Oncology Inc (NASDAQ: POAI) Trading Performance Indicators
Take a look at Predictive Oncology Inc’s (POAI) current performance indicators. Last quarter, stock had a quick ratio of 1.06. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.06, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.13 in one year’s time.
Technical Analysis of Predictive Oncology Inc (POAI)
Let’s dig in a bit further. During the last 5-days, its volume was 0.32 million. That was inferior than the volume of 3.18 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 12.22%. Additionally, its Average True Range was 0.18.
During the past 100 days, Predictive Oncology Inc’s (POAI) raw stochastic average was set at 28.29%, which indicates a significant increase from 2.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 154.82% in the past 14 days, which was higher than the 144.27% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2938, while its 200-day Moving Average is $1.0611. However, in the short run, Predictive Oncology Inc’s stock first resistance to watch stands at $1.4067. Second resistance stands at $1.5533. The third major resistance level sits at $1.6367. If the price goes on to break the first support level at $1.1767, it is likely to go to the next support level at $1.0933. Assuming the price breaks the second support level, the third support level stands at $0.9467.
Predictive Oncology Inc (NASDAQ: POAI) Key Stats
The company with the Market Capitalisation of 9.08 million has total of 6,846K Shares Outstanding. Its annual sales at the moment are 1,780 K in contrast with the sum of -13,980 K annual income. Company’s last quarter sales were recorded 350 K and last quarter income was -3,090 K.
